These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4123574)

  • 1. Lymphocyte transformation in malignant disease.
    Edwards AJ; Lee MR
    Lancet; 1973 May; 1(7813):1186-7. PubMed ID: 4123574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on lymphocyte subpopulation, T cell subsette and lymphocyte responses to lectin of patients with malignant tumors].
    Oki H; Isshiki T; Sasano M; Takashima A; Chinen Y
    Rinsho Byori; 1984 Feb; 32(2):159-64. PubMed ID: 6610777
    [No Abstract]   [Full Text] [Related]  

  • 3. [T- and B-lymphocyte counts and their function in patients with primary liver cancer and alveococcosis].
    Strazhnikova GA; Sukhorukov VP; Voronchikhina LD; Korshunova TP; Gornostaeva GN
    Vopr Onkol; 1984; 30(1):56-9. PubMed ID: 6607570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the effect of serum from patients with neoplasms on lymphocyte transformation].
    Vergnano F; Cavallero P; Fazio M; Sartoris S
    Boll Soc Ital Biol Sper; 1977 Nov; 53(21):1894-7. PubMed ID: 304734
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed cellular immunity in hepatocellular carcinoma patients.
    Lee CS; Chang KJ; Lin TY; Hsieh KH; Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1981 Aug; 80(8):780-5. PubMed ID: 6273493
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered activation pathways in T lymphocytes infiltrating human solid tumors.
    Miescher S; Stoeck M; Whiteside TL; Leyvraz S; Ruzicka J; Schindler AM; Givel JC; Mosimann F; von Fliedner V
    Transplant Proc; 1988 Apr; 20(2):344-6. PubMed ID: 3259038
    [No Abstract]   [Full Text] [Related]  

  • 8. Diminished helper-T-lymphocyte function in cancer patients.
    Umeda T; Hara T; Koseki K; Kobayashi K; Akaza H; Niijima T
    Cell Mol Biol; 1982; 28(1):67-71. PubMed ID: 6211238
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: T and B lymphocytes in spleens of patients with malignant diseases.
    Kaur J; Spiers AS; Galton DA
    Lancet; 1975 Mar; 1(7909):747. PubMed ID: 47510
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral factors influencing lymphocyte transformation.
    Nelson DS; Gatti RA
    Prog Allergy; 1976; 21():261-341. PubMed ID: 63955
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of the immune system in cancer patients.
    Van Gool SW; Van Den Hove L; Ceuppens JL
    Med Pediatr Oncol; 2000 Jan; 34(1):1-9. PubMed ID: 10611577
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer cells in effusions and increases in T-activated lymphocytes.
    Geuna M; Linari A; Bussolati G
    Eur J Cancer; 1990; 26(7):852-3. PubMed ID: 2145916
    [No Abstract]   [Full Text] [Related]  

  • 13. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte transformation in malignant disease.
    Lancet; 1973 Apr; 1(7809):937. PubMed ID: 4123865
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonogenic and functional potential of T lymphocytes infiltrating human solid tumors.
    von Fliedner V; Qiao L; Whiteside TL; Leyvraz S; Barras C; Miescher S
    Prog Clin Biol Res; 1987; 244():223-32. PubMed ID: 3498950
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.
    Yachnin S
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological profile of patients with neoplastic disease].
    Stivala F; Catania G; Basile F; Malaponte G; Bottiglieri C; Giovinetto A
    Minerva Chir; 1981 Mar; 36(5):297-302. PubMed ID: 6972495
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte mediated natural cytotoxicity in neoplasia.
    Menon M; Stefani SS
    Oncology; 1978; 35(2):63-7. PubMed ID: 306592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in cancer; can they be controlled?
    Adeegbe DO; Nishikawa H
    Immunotherapy; 2015; 7(8):843-6. PubMed ID: 26316166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.